MedicaidAdministrativeLow impact
Newsletter Vol. 3, No. 35
New Jersey Medicaid·NJ·Pharmacy
We identified it
Jun 20, 2026
Summary
This policy update pertains to the Pharmaceutical Assistance to the Aged and Disabled (PAAD) Drug Manufacturers' Rebate Program in New Jersey. The policy involves pharmaceutical rebate regulations under New Jersey state law that may affect pharmacy billing and reimbursement processes.
Action Required
Review Newsletter Vol. 3, No. 35 from NJ MMIS to understand any changes to pharmaceutical rebate processing for PAAD-eligible patients. Contact pharmacy benefit coordinators to verify if any billing workflow adjustments are needed for New Jersey Medicaid pharmaceutical claims.